Position in TLRY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,039,285
-$2,185,630 QoQ
Shares Held
454,184
-30.4% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 235 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Derivatives in TLRY
reported options exposure · as of Dec 31, 2023CallValue
$660,330
CallShares
28,710
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. TLRY ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in TLRY
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,039,285 | 454,184 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,224,915 | 653,001 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $7,030,693 | 778,593 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,803,248 | 2,776,445 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,402,935 | 3,421,796 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,242,486 | 4,912,859 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,308,161 | 2,487,340 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $622,208 | 353,529 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $250,188 | 150,717 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $294,706 | 119,315 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $285,196 | 123,999 | Shares | Defined | 2024-02-09 | |
| 2023-12-31 | $660,330 | 287,100 | Call | Defined | 2024-02-09 | |
| 2023-09-30 | $298,697 | 124,979 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $19,444 | 12,465 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $110,873 | 43,824 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $120,264 | 44,708 | Shares | Defined | 2023-02-08 | |
| 2022-12-31 | $269 | 100 | Call | Defined | 2023-02-08 | |
| 2022-09-30 | $183,163 | 66,605 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $102,226 | 32,765 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $139,860 | 18,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $906,840 | 128,996 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,492,199 | 132,170 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,651,933 | 91,368 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,273,000 | 100,000 | Put | Defined | 2021-05-12 | |
| 2021-03-31 | $2,366,465 | 104,112 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,229,509 | 148,851 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $106,700 | 22,000 | Call | Defined | 2020-11-12 | |
| 2020-09-30 | $529,658 | 109,208 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,072,651 | 854,100 | Call | Defined | 2020-07-31 | |
| 2020-06-30 | $309,917 | 43,589 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $84,575 | 12,293 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||